BDBM72346 1-(2-furanylmethyl)-3-[1-(4-methoxyphenyl)ethylideneamino]thiourea::1-(2-furfuryl)-3-[1-(4-methoxyphenyl)ethylideneamino]thiourea::1-(4-methoxyphenyl)ethanone N-(2-furylmethyl)thiosemicarbazone::1-(furan-2-ylmethyl)-3-[1-(4-methoxyphenyl)ethylideneamino]thiourea::MLS000701372::SMR000225233::cid_829176

SMILES COc1ccc(cc1)C(C)=NNC(=S)NCc1ccco1

InChI Key InChIKey=YAMVRZQHRYYQSF-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72346   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72346BDBM72346(3-Bromo-2,8-difluoro-10,11,12,13-tetrahydro-19H-5,...)
Affinity DataIC50: 10nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details US Patent